Renal safety of tenofovir disoproxil fumarate in HIV-1 treatment-experienced patients with adverse events related to prior NRTI use: data from a prospective, observational, multicenter study.
Moreno
Santiago
S
Domingo
Pere
P
Palacios
Rosario
R
Santos
Jesús
J
Falcó
Vicenç
V
Murillas
Javier
J
Estrada
Vicente
V
Ena
Javier
J
Alvarez
Maria Luisa
ML
D000225:Adenine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000328:Adult; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1; D006801:Humans; D007668:Kidney / Q000187:drug effects*; D008875:Middle Aged; D063065:Organophosphonates / Q000009:adverse effects* / Q000627:therapeutic use; D011446:Prospective Studies; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D000068698:Tenofovir
D063065:Organophosphonates; D018894:Reverse Transcriptase Inhibitors; D000068698:Tenofovir; D000225:Adenine